Lv2
130 积分 2025-03-21 加入
Increased risk of telogen effluvium with tirzepatide compared to other weight loss medications: A retrospective cohort TriNetX database study
14小时前
已关闭
Topical Vehicles: A Dermatologist's Perspective
10天前
已关闭
Prevalence and Predictors of Hair Shedding among GLP-1 Receptor Agonist Users: A Cross-Sectional Study from Saudi Arabia
11天前
已完结
Prevalence and Predictors of Hair Shedding among GLP-1 Receptor Agonist Users: A Cross-Sectional Study from Saudi Arabia
11天前
已关闭
JAAD CME Part 2: Clinical Evidence and Safety Considerations for GLP-1 Receptor Agonists in Dermatology
11天前
已关闭
Increased risk of telogen effluvium with tirzepatide compared to other weight-loss medications: a retrospective cohort TriNetX database study
11天前
已完结
Adverse drug reaction patterns of GLP ‐1 receptor agonists approved for obesity treatment: Disproportionality analysis from global pharmacovigilance database
11天前
已完结
The Wide World of Glucagon-like Peptide-1 Agonist Therapy: The Thrill of Weight Loss and the Agony of Alopecia
11天前
已关闭
皖公网安备34019202002308
